Category: 3. Business

  • Samsung Expands Home Appliance Remote Management (HRM) Service Globally to Enhance Customer Experience – Samsung Newsroom Canada

    Samsung Expands Home Appliance Remote Management (HRM) Service Globally to Enhance Customer Experience – Samsung Newsroom Canada

    Now available in 122 countries and 17 languages, HRM delivers faster, more seamless customer support across borders

     

    Samsung Electronics Co., Ltd is expanding it Home Appliances Remote Management (HRM) service globally, enhancing the remote diagnostic and troubleshooting experience for smart appliances users around the world. The service is now active across 122 countries including Canada with support for 17 languages, enabling seamless support for a wide global customer base.

     

    HRM is a service that connects SmartThings-connected appliances to Samsung’s service network, maintaining a continuous record of device conditions and enabling real-time monitoring through the service center.

     

     

    “Samsung’s HRM service exemplifies our commitment to proactive, smart customer care,” said Miyoung Yoo, EVP and Head of Global Customer Satisfaction Team, Digital Appliance (DA) Business at Samsung Electronics. “Thanks to the combination of seamless connectivity and real-time insights, this service helps to reduce complexity for our customers, ultimately enhancing their overall satisfaction.”

     

    Enhancing Service for Screen Appliances

    In line with the expansion of screen-equipped appliances like Bespoke refrigerators and washing machines, Samsung has also introduced a screen-sharing feature to enhance diagnostic capabilities. For various screens of 7”, 9”, and Family Hubs, its users can share their device screens in real time with service centre advisors, allowing diagnosis of display-related issues, app malfunctions or multimedia playback problems.

     

    Immediate Solutions and Reduced Service Visits through Remote Assistance

    Samsung’s HRM service improves a new avenue for customer care by enabling real-time remote solutions for simple product issues that previously required in-home technician visits. For instance, for a customer that reported that the washing machine’s buttons were not responding, the advisor was able to diagnose through the HRM system that the Child Lock setting was active. With simple guidance on how to disable the setting, the problem was solved instantly without a technician’s visit. In another case where a customer reported condensation on the refrigerator door, with user consent, the advisor was able to remotely turn on the internal heater, which effectively eliminated the moisture.

     

    In cases when an on-site visit is ultimately necessary, HRM improves the experience by allowing technicians to review detailed diagnostic data in advance. They are able to arrive at the site prepared, potentially reducing repeat visits and repair times.

     

    Growing Adoption and User Satisfaction

    With the continued expansion of customer support solutions like HRM, Samsung is realizing convenient and efficient ways to care for home appliances – reducing downtime, enhancing the user experience and setting new standards for global service. As HRM reaches more countries, languages and product categories, Samsung remains committed to delivering smarter, more connected care for the homes of the future.

     

     

     

     

    HRM is supported on SmartThings-enabled models released after 2019. Must download the SmartThings app available on Android and iOS devices. A Wi-Fi connection and a Samsung account are required.
    In Korea, HRM supports refrigerators, washing machines, dryers, air conditioners, vacuum cleaners, and dishwashers. In Canada, HRM supports refrigerators and washing machines.

    Continue Reading

  • Trump, Nvidia, and Apple Just Flipped the Script

    Trump, Nvidia, and Apple Just Flipped the Script

    This article first appeared on GuruFocus.

    Intel’s (NASDAQ:INTC) comeback could be one of the most surprising corporate turnarounds this year. After President Donald Trump publicly called for CEO Lip-Bu Tan’s resignation earlier this summer, few expected the story to flip this fast. But it did. Since the White House signaled plans to take a 10% stake in Intel, the company’s shares have climbed more than 50%, marking one of its strongest rallies in years. The political backing ignited a string of high-profile investmentsSoftBank committed $2 billion, followed by Nvidia’s (NASDAQ:NVDA) $5 billion partnership deal to co-develop chips for PCs and data centers. Reports also suggest Apple has explored a potential collaboration, though talks remain preliminary.

    Beyond the headlines, Intel is quietly rebuilding the core of its business. The company confirmed that its next-generation Panther Lake chips, built on its 18A manufacturing process, are now in full production and slated for laptops early next year. This technology marks Intel’s long-awaited return to producing its most advanced chips in-house after years of outsourcing to TSMC. Intel’s management views the 18A process as a critical testone that could finally position its foundry unit to win new contracts from major designers like Nvidia and Apple (NASDAQ:AAPL), provided the performance holds up under industry scrutiny.

    The next phase, however, may hinge on execution rather than momentum. Nvidia said it will monitor Intel’s progress before committing further, while Apple’s potential involvement could start with simpler products such as Apple TV chips. Still, Intel’s strengthened relationship with Washington could prove strategically valuable, offering companies a politically favored path to build in America without constructing their own facilities. Investors seem to sense that Intel’s reset is gaining tractionbut transforming optimism into long-term customer demand will be the real test of whether Lip-Bu Tan’s turnaround plan can endure.

    Continue Reading

  • Levi Strauss Shares Fall as Tariff Costs Cloud Profit Outlook

    Levi Strauss Shares Fall as Tariff Costs Cloud Profit Outlook

    This article first appeared on GuruFocus.

    Levi Strauss & Co. (LEVI, Financials) shares fell almost 7% in premarket trade on Friday.The denim maker said that new tariffs would affect fourth-quarter margins, even as it raised its full-year profit outlook.

    The San Francisco-based garment manufacturer said that higher import costs from places like Bangladesh, Cambodia, and Pakistan, which have high tariffs under current U.S. trade policies, will cut gross margins by 130 basis points.

    The estimate shows how changing U.S. trade regulations could affect global supply chains, especially for retailers who do a lot of business in places that don’t have free trade. Levi’s said it got around 70% of their holiday stock early and hiked some prices to make up for the tariff hit.

    Investors were more worried about the impact on margins, even while sales were going up and younger buyers were still buying baggy and loose-fitting clothes. Barclays analysts called the outlook cautious, while Morgan Stanley said the guidance meant that the holiday quarter will be weaker since it would be harder to compare to the same quarter last year.

    Levi’s stock has gone up approximately 40% this year because they have better control over their inventories and more full-price sales. Its forward price-to-earnings ratio is about 17, which is lower than Ralph Lauren’s 20.6 and higher than American Eagle Outfitters’ 11.4.

    The company’s next big test will be how it deals with tariffs throughout the holiday season while keeping prices high and demand strong.

    Continue Reading

  • Chinese firm planning £1.5bn turbine plant in Scotland

    Chinese firm planning £1.5bn turbine plant in Scotland

    PA Media A ship passing between two offshore wind turbines on a dark blue sea under a light blue sky with grey and white clouds.PA Media

    Ming Yang says it wants to invest up to £1.5bn in building the facility in the Highlands

    A Chinese energy company has announced plans to build the UK’s largest wind turbine manufacturing facility in Scotland.

    Ming Yang said the £1.5bn project would create up to 1,500 jobs, with the first production taking place by late 2028.

    The firm, which is the largest private wind turbine manufacturer in China, has shortlisted the green freeport site at Ardersier as its preferred location for the facility.

    Ming Yang said it would invest up to £750m in the first phase of its investment before expanding to create an “offshore wind industry ecosystem” around the hub.

    It has been in talks with the Scottish and UK governments over the past two years.

    The firm’s UK chief executive, Aman Wang said: “We firmly believe that by moving forward with our plans to create jobs, skills and a supply chain in the UK, we can make this country the global hub for offshore wind technology.

    “We fully support the government’s mission to become a clean energy superpower, and I’m confident that once the plans are approved we can make a valued contribution to this goal.”

    But a Conservative MP has previously questioned the wisdom of letting the company invest in the UK.

    Last November, MP Nick Timothy asked UK energy minister Michael Shanks about Ming Yang’s plans to invest in Scotland, saying the government should rule out investment from “hostile states”.

    Timothy said Ming Yang “benefits from huge subsidies in China,” adding any investment was subject to “serious questions about energy and national security”.

    The UK government’s Energy Secretary, Michael Shanks, said he would “encourage investment”.

    In a statement released on Friday, a UK government spokesperson said: “This is one of a number of companies that wants to invest in the UK.

    “Any decisions made will be consistent with our national security.”

    Continue Reading

  • Navigating Metastatic CRC Treatment Options in Later Lines | Targeted Oncology

    Navigating Metastatic CRC Treatment Options in Later Lines | Targeted Oncology

    In the later-line treatment of metastatic colorectal cancer (CRC), options become more limited and are often guided by prior therapies and biomarker status. Michael J. Overman, MD, associative vice president of research, Cancer Network, Division of Cancer Medicine and professor at The University of Texas MD Anderson Cancer Center, moderated the discussion at a live Case-Based Roundtable event in Dallas, Texas. Overman detailed the use of liquid and tumor biopsies for rapid molecular profiling to inform frontline decisions. He also reviewed key third-line regimens, and the consideration of anti-EGFR rechallenge in selected patients.

    Register today to join a Case-Based Roundtable near you.

    CASE SUMMARY

    • A 58-year-old female teacher was diagnosed with metastatic CRC 3 years ago. The primary tumor was in the sigmoid colon with metastatic lesions in the liver and peritoneal implants.
    • Tumor genomics: microsatellite stable (MSS), RAS wild type, BRAF wild type, HER2 negative, low tumor mutational burden
    • Medical history: controlled hypertension, type 2 diabetes, and history of deep vein thrombosis 5 years ago

    Treatment

    • Received folinic acid/fluorouracil/oxaliplatin/bevacizumab in first line with initial partial response; progression after 11 months of therapy; during treatment patient experienced grade 2 peripheral neuropathy, which stabilized with oxaliplatin dose reduction
    • Received folinic acid/fluorouracil/irinotecan/cetuximab in second line with initial disease control; progression after 8 months of therapy; patient experienced grade 1 skin rash that was managed with topical treatments
    • Currently, patient reports grade 1 fatigue that worsens toward the end of each treatment cycle and grade 1 myelosuppression. Last imaging showed mixed response with no new lesions.
    • ECOG performance status: 1 (intermittently grade 2 for several days after each chemotherapy cycle)

    Laboratory results

    • White blood cell count: 3.2 x 109/L
    • Hemoglobin: 10.2 g/dL
    • Platelets: 95 x 109/L
    • Alanine aminotransferase: 65 U/L
    • Aspartate aminotransferase: 58 U/L

    Targeted Oncology: What testing do you normally get for patients with CRC such as this?

    Michael J. Overman, MD: At MD Anderson Cancer Center, we do a lot of testing, but we do liquid biopsy to get at that issue so that we get a molecular test back quickly. We also do the tumor because it’s bigger, so we do both. That’s not [the most] health economic but that’s our approach to getting it because of the issue of, by the time you get your NGS, you already started therapy…. I don’t know if a lot of people do that, if you have the same issue in the front line for liquid biopsy these days. I think it’s even more relevant now because of the BRAF mutations. Now BRAF [inhibition] is frontline therapy.

    How does circulating tumor DNA (ctDNA) factor in in these kinds of cases where there’s mixed response?

    For colon cancer, we have carcinoembryonic antigen [CEA], which is a pretty good surrogate. I think ctDNA would probably be a more accurate surrogate, if you had it, but you’d have to be tracking it over time. We do a ton of minimal residual disease testing.

    The best data, I think, on treatment, is immunotherapy [IO]-based data. There are some really good IO data with ctDNA, I think a good early predictor of IO benefit and addresses that pseudo-progression issue that sometimes can come up. The data are really good there. I think on systemic therapy, it’s a good readout. It’s just a more accurate CEA, to some degree. Right now, how much is it an aid to what you already have? I don’t know if we do it in the metastatic setting for following; we do it for profiling up front. That’s where we try to get our HER2 amplification, BRAF, or NRAS testing, and be able to make a frontline decision by doing liquid biopsy. But it does get you to where you end up doing both. If we have time to wait, then just do tumor biopsy and wait. That’s fine, but often they don’t want to wait 3 to 4 weeks.

    What are the second-line therapy options for this patient with metastatic CRC?

    In the NCCN, we have the biomarker-directed therapies for HER2, KRAS G12C, BRAF, and more in the frontline. For previous therapy [with oxaliplatin and irinotecan], we have fruquintinib [Fruzaqla], regorafenib [Stivarga], trifluridine/tipiracil [Lonsurf], and trifluridine/tipiracil/bevacizumab. That would be the third-line options.

    The treatment here that I don’t think they list that we sometimes do is the anti-EGFR re-challenge. In this case, the patient had second-line EGFR treatment, but if they had frontline EGFR, [it might be an option]. There are small data sets for EGFR rechallenge. They’re smaller randomized studies, but there are some; the data are definitely much more solid for treatments such as trifluridine/tipiracil/bevacizumab or fruquintinib. I can talk about regorafenib, but regorafenib has some issues.

    We would say our approach would be time off from prior EGFR treatment, and then we often do a liquid biopsy to make sure they don’t have any persistent MAP kinase alterations. The data are clear that if a patient has a persistent RAS or MAP kinase alteration, they don’t get benefit. So that would be our approach, and response rates have been pretty consistent, [up to] 20% for EGFR rechallenge in that setting.1 It’s something we do consider in a certain setting. But I would probably put it later [rather] than earlier. The one thing where we do use it is that EGFR rechallenge does give them a response, whereas some of these agents are…more cytostatic, so you get more survival benefit, but not response benefit. So if you really need a response, then that sometimes is something we consider for that sole reason.

    How often are you seeing KRAS G12C and NTRK mutations in these patients?

    It’s rare; it’s [around 3%].2 It’s a rare kind of KRAS variant in colon cancer. The NTRK and the other fusions are really rare. The fusions tend to be more common in patients with microsatellite instability [MSI].3 So MSI patients tend to have a much higher fusion rate than MSS. In standard colon cancer, it’s less than 1% but it’d be a little more common in MSI. I have seen them. NTRK [inhibitors] do work, but it’s super rare.

    Register today to join a Case-Based Roundtable near you.

    DISCLOSURES: Overman previously reported consulting for 3T Biosciences, Agenus, Array, Bayer, Gritstone, Janssen, Merck, Merus, Pfizer, Summit Therapeutics, and Takeda, and grants/research support from Bristol Myers Squibb, Lilly, Medimmune, Merck, Nouscom, Phanes, Roche, and Takeda.

    References:

    1. Sartore-Bianchi A, Pietrantonio F, Lonardi S, et al. Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial. Nat Med. 2022;28(8):1612-1618. doi:10.1038/s41591-022-01886-0

    2. Strickler JH, Yoshino T, Stevinson K, et al. Prevalence of KRAS G12C mutation and co-mutations and associated clinical outcomes in patients with colorectal cancer: A systematic literature review. Oncologist. 2023;28(11):e981-e994. doi:10.1093/oncolo/oyad138

    3. Wang H, Li ZW, Ou Q, et al. NTRK fusion positive colorectal cancer is a unique subset of CRC with high TMB and microsatellite instability. Cancer Med. 2022;11(13):2541-2549. doi:10.1002/cam4.4561

    Continue Reading

  • Gold surges near $4,000 as US–China trade tensions ignite haven demand

    Gold surges near $4,000 as US–China trade tensions ignite haven demand

    Gold price rises during the North American session on Friday amid an escalation of the trade war between the US and China. This, the US government shutdown and expectation for further easing by the Federal Reserve (Fed) keep the yellow metal bid. XAU/USD trades at $3,997, up 0.60%, at the time of writing.

    Bullion’s boosted by escalating tariff threats and prolonged Washington deadlock reigniting risk aversion

    Risk aversion is the name of the game after US President Donald Trump warned of possible fresh duties on China, as the latter threatens to impose export controls on rare earths. Trump added that there is no reason to meet with China’s President Xi Jinping in two weeks in South Korea as planned.

    On Thursday, the yellow metal posted losses of 1.59% as traders booked profits, along with the ceasefire between Israel and Gaza.

    The US government shutdown extends to the tenth straight day and the chances of a reopening in the near term remain far.

    Data-wise, the University of Michigan (UoM) revealed that Consumer Sentiment was steady in October, as households appear to shrug off the partial shutdown of the government.

    Next week, the US economic docket is expected to release the Consumer Price Index (CPI) for September. Nevertheless, the US Bureau of Labor Statistics (BLS) revealed that it will be announced on Friday at 8:30 AM ET.

    Daily market movers: Gold rallies amid global political turmoil

    • Geopolitics are also playing their part on Gold prices. The political turmoil in France and Japan increases Bullion’s appeal.
    • Reuters revealed that French President Emmanuel Macron won’t appoint a left-wing PM, triggering anger amongst leaders. Some of Macron’s opponents have urged him to either call fresh legislative elections or step down—options he has so far firmly resisted.
    • In Japan, the election of Sanae Takaichi to become the first female Prime Minister is in doubt, as Komeito leader Tetsuo Saito said the two parties’ 26-year partnership had broken down over the LDP’s failure to respond to a political funding scandal that has dogged the ruling group for two years. The parliamentary vote will be held in the second half in October.
    • Bullion is pressured as the US Dollar strengthens sharply across the board. The US Dollar Index (DXY), which tracks the performance of the buck’s value against a basket of six currencies, slides 0.43% down to 98.97.
    • The US 10-year Treasury note yield plummets nine basis points to 4.048%. US real yields — which correlate inversely to Gold prices — are also diving nine and a half bps to 1.708%.
    • St. Louis Fed President Alberto Musalem said that Fed goals are in tension, as inflation runs high and the labor market shows signs of softening. He said that although policy is between modestly restrictive and neutral, the financial conditions are accommodative.
    • Goldman Sachs updated its Gold forecasts for 2026 from $4,300 to $4,900, citing strong flows into Gold ETFs and central bank demand.
    • Money markets indicate that the Fed will cut interest rates by 25 basis points (bps) at the upcoming October 29 meeting. The odds stand at 94%, according to the Prime Market Terminal interest rate probability tool.

    Technical outlook: Gold’s advances, but halts around $4,000

    Gold’s technical picture remains bullish, though a daily close above $4,000 could cement the case for higher prices next week, with the all-time high sitting at $4,059. Otherwise, XAU/USD could be poised for a pullback, with sellers’ eyes on the October 1 high turned support at $3,895. A breach of the latter will expose the 20-day Simple Moving Average (SMA) at $3,818.

    From a momentum standpoint, the Relative Strength Index (RSI) shows that buyers remain in charge, despite being overbought above 70 . However, the strong upward trend suggests that higher readings above the 80 level to seen as an overextended trend up. 

    Gold FAQs

    Gold has played a key role in human’s history as it has been widely used as a store of value and medium of exchange. Currently, apart from its shine and usage for jewelry, the precious metal is widely seen as a safe-haven asset, meaning that it is considered a good investment during turbulent times. Gold is also widely seen as a hedge against inflation and against depreciating currencies as it doesn’t rely on any specific issuer or government.

    Central banks are the biggest Gold holders. In their aim to support their currencies in turbulent times, central banks tend to diversify their reserves and buy Gold to improve the perceived strength of the economy and the currency. High Gold reserves can be a source of trust for a country’s solvency. Central banks added 1,136 tonnes of Gold worth around $70 billion to their reserves in 2022, according to data from the World Gold Council. This is the highest yearly purchase since records began. Central banks from emerging economies such as China, India and Turkey are quickly increasing their Gold reserves.

    Gold has an inverse correlation with the US Dollar and US Treasuries, which are both major reserve and safe-haven assets. When the Dollar depreciates, Gold tends to rise, enabling investors and central banks to diversify their assets in turbulent times. Gold is also inversely correlated with risk assets. A rally in the stock market tends to weaken Gold price, while sell-offs in riskier markets tend to favor the precious metal.

    The price can move due to a wide range of factors. Geopolitical instability or fears of a deep recession can quickly make Gold price escalate due to its safe-haven status. As a yield-less asset, Gold tends to rise with lower interest rates, while higher cost of money usually weighs down on the yellow metal. Still, most moves depend on how the US Dollar (USD) behaves as the asset is priced in dollars (XAU/USD). A strong Dollar tends to keep the price of Gold controlled, whereas a weaker Dollar is likely to push Gold prices up.

    Continue Reading

  • Emerging Markets Stocks and Currencies Are Forecast to Rally

    Emerging Markets Stocks and Currencies Are Forecast to Rally

    Macroeconomic factors could also support EM stocks. The US Fed is forecast to cut rates further, creating room for further monetary easing and stronger growth across a number of emerging markets, Trivedi writes.

    And the US dollar “will likely stay on the back foot” relative to emerging markets currencies amid a softening US labor market and a potential increase in investment flows into EM stocks and bonds as investors diversify away from the dollar. A weakening dollar can boost flows into EM stocks as investors look for higher returns outside the US.

    Which Stock Markets Are Forecast to Grow?

    Within Asian markets, Goldman Sachs Research sees investment opportunities in Chinese and Korean equities.

    In Korea, 70% of stocks trade below book value (the implied value of a stock based on the company’s assets minus its liabilities). Ongoing reforms to the way companies are governed in Korea could also drive up the country’s equity prices, as could Chinese efforts to address disorderly price cutting and excessive competition among producers.

    Meanwhile, Saudi Arabian equities could benefit from the potential easing of limits on foreign ownership of listed companies, which Goldman Sachs Research estimates could unlock passive inflows up to $10 billion to the Saudi markets.

    “On balance, this should be supportive of Saudi equities—which have lagged EM in the year to date—and fits with our regional diversification theme,” Trivedi writes.

    On the other hand, Indian equities have lagged other emerging markets this year. High valuations, higher-than-expected tariffs, and challenges for the software sector from the increased price of US H1B visas suggest that a broad recovery might not be imminent.

    Beyond Asia, the team anticipates continued gains from South African stocks as rising gold prices help mining companies and inexpensive domestic sectors could benefit from a potential growth recovery and lower borrowing costs.

    Why are emerging currencies strengthening against the US dollar?

    Emerging market currencies outperformed their peers from major developed economies in September, and Goldman Sachs Research anticipates that this outperformance could continue.

    There are three key factors supporting the appreciation of EM currencies relative to their DM peers. Firstly, high levels of carry (when investors borrow currency in a country with lower interest rates in order to invest somewhere with higher rates) are contributing to the attractiveness of emerging markets currencies relative to other major currencies.

    Secondly, the team notes that the US dollar has been acting more like a cyclical currency lately—one which appreciates as the economy grows and declines when the economy is under pressure—particularly when a shock emanates from the US.

    As a result, EM currencies are likely to weaken less significantly against the dollar in the event of changes to risk sentiment or downward revisions to growth expectations in the US.

    And finally, the strong performance of EM equities is also likely to have played a role in the appreciation of EM currencies relative to their developed market peers.

    The team has found that there is a relationship between the performance of EM currencies and relative equity returns. In short, “the best environment for EM foreign exchange is when both the MSCI EM and S&P indices are going up and MSCI EM is outperforming,” Trivedi writes.

     

    This article is being provided for educational purposes only. The information contained in this article does not constitute a recommendation from any Goldman Sachs entity to the recipient, and Goldman Sachs is not providing any financial, economic, legal, investment, accounting, or tax advice through this article or to its recipient. Neither Goldman Sachs nor any of its affiliates makes any representation or warranty, express or implied, as to the accuracy or completeness of the statements or any information contained in this article and any liability therefore (including in respect of direct, indirect, or consequential loss or damage) is expressly disclaimed.

    Continue Reading

  • Trump threatens to pull out of planned Xi meeting

    Trump threatens to pull out of planned Xi meeting

    President Donald Trump has threatened to pull out of an expected meeting with President Xi Jinping of China after Beijing tightened its rules for exports of rare earths.

    In a post on social media, Trump said he now saw “no reason” to meet with President Xi later this month, accusing China of “becoming very hostile” and trying to hold the world “captive”.

    He also threatened a “massive” increase in tariffs on Chinese goods, raising fears about further escalation of trade tensions between the two economic giants.

    Financial markets dropped in the wake of the remarks, with the S&P 500 down 1.8% in mid-afternoon trade in New York.

    The last time Beijing tightened export controls – after Trump raised tariffs on Chinese goods early this year – there was an outcry from many US firms reliant on the materials . Carmaker Ford even had to temporarily pause production.

    In addition to tightening rules for rare earth exports, China has opened a monopoly investigation into the US tech firm Qualcomm that could stall its acquisition of another chipmaker.

    Although Qualcomm is based in the US, a significant portion of its business is concentrated in China.

    Beijing has also said it will charge new port fees to ships with ties to the US, including those owned or operated by US firms.

    “Some very strange things are happening in China!” Trump wrote in a post on social media on Friday. “They are becoming very hostile.”

    The US and China have been in a fragile trade détente since May, when the two sides agreed to drop triple-digit tariffs on each others’ goods that had nearly stopped trade between the two countries.

    Officials have held a series of talks since then on matters including TikTok, agricultural purchases, and the trade of advanced technology like semiconductors and rare earths supplied by China, which are key components in cars, smartphones and many other items.

    The two sides were expected to meet again this month at a summit in South Korea.

    China expert Jonathan Czin, a fellow at the Brookings Institution, said Xi’s recent actions were a bid to shape the upcoming talks, noting that the recent rare earths directive does not go into effect immediately.

    “He’s looking for ways to seize the initiative,” he said. “The Trump administration is having to play a game of whack-a-mole and deal with these issues as they come up.”

    He added that he did not think China was worried about US retaliation in response.

    “What China took away from the Liberation Day tariffs and the cycle of escalation followed by de-escalation is that the Chinese side had a higher pain threshold,” he said. “From their perspective, the Trump administration blinked.”

    In prior rounds of trade talks, China has pushed for looser US restrictions on semiconductors. It is also interested in securing more stable tariff policies that would make it easier for its businesses to sell into the US.

    Xi has previously used as leverage his country’s dominance of production of rare earths, critical minerals and other materials.

    But the export rules unveiled this week target overseas defence manufacturers, making them particularly serious, said Gracelin Baskaran, director of the critical minerals security program at Washington-based Center for Strategic and International Studies.

    “Nothing makes America move like targeting our defence industry,” she said. “The US is going to have to negotiate because we have limited options, and in an era of rising geopolitical tension and potential conflict, we need to build our industrial defence base.”

    While a Trump-Xi meeting now looks unlikely, she said it was not necessarily completely off the table. Ms Baskaran said there’s still time and room for talks. China’s new rules don’t take effect until December.

    “Negotiations are likely imminent,” she said. “Who does them and where they happen will be determined with time.”

    Continue Reading

  • Planet announces new line of satellites for daily Earth imaging

    Planet announces new line of satellites for daily Earth imaging

    AUCKLAND, New Zealand — Planet has announced a new class of imaging satellites that will replace a line of spacecraft dating back to the company’s earliest days.

    Will Marshall, co-founder and chief executive of Planet, wrote in an Oct. 7 blog post that the company will launch late next year the first Owl satellite, intended to ultimately replace its existing fleet of SuperDove satellites.

    “Owl will be designed to deliver frequent, best-in-class imagery faster, enabling customers to receive imagery-enabled insights within as little as one hour of capture,” he said.

    Unlike SuperDoves, which provide imagery at a resolution of three to four meters, the Owl spacecraft will offer one-meter imagery. The spacecraft will also be equipped with Nvidia processors to enable “AI at the edge” onboard processing, such as identifying objects or detecting activity of interest.

    The Owl satellites will maintain what Marshall called “seamless continuity” with SuperDoves by using the same core spectral bands, allowing customers to use existing workflows for analyzing the imagery.

    Through imagery from the Dove and SuperDove satellites, Planet has built a daily record of Earth’s surface. “We have an eight-year daily history of change on the planet everywhere,” Robbie Schingler, co-founder and chief strategy officer of Planet, said in an Oct. 8 speech at the New Zealand Aerospace Summit. “It has become a foundational data layer.”

    The new satellites, however, will be significantly different physically from SuperDoves. Illustrations released by Planet showed a spacecraft that appeared larger than the 3U cubesat form factor used by SuperDoves and earlier Dove satellites dating back more than a decade. A company spokesperson confirmed that the Owl satellites are larger but declined to provide their mass or dimensions.

    “Looking ahead, a higher-performance and future-proofed mission requires a more capable and advanced spacecraft,” Marshall wrote. The Owl satellites will use an upgraded version of the avionics system developed for the larger Pelican and Tanager satellites Planet is building for high-resolution and hyperspectral imagery, respectively.

    He said the first technology demonstration for Owl will launch in late 2026, with a fleet of spacecraft to follow in the “coming years.”

    The announcement of Owl comes as Planet scales up production of the larger Pelican satellites. The company announced Sept. 25 that it will establish a second factory for Pelican satellites in Berlin, its European headquarters. The new factory, Planet said, will help it “better meet growing demand from the European market” by doubling the production rate for those spacecraft.

    Schingler noted in his talk that the company continues to be vertically integrated in its satellite production. “That’s really showing the immaturity of the space segment today. It’s really a community today. It’s not a huge, efficient, competitive, interoperable market.”

    “I don’t want to be vertically integrated. We’ve had to be vertically integrated because the maturity of the supply chain wasn’t there,” he said. He cited, as an example, 18-month lead times for avionics as a reason the company produces them and other components in-house.

    He said he wants to see the space industry become more like the semiconductor market, where supply chains are more reliable and efficient. “I think the future for us is to be a true market, a true industry,” he said, with a strong supply chain that can provide components quickly. “That’s what I really wish for the ecosystem, to turn into an industry where you don’t have to be vertically integrated.”

    Continue Reading

  • Major US online retailers remove listings for millions of prohibited Chinese electronics

    Major US online retailers remove listings for millions of prohibited Chinese electronics

    • FCC says millions of listings for Chinese electronics on U.S. online retailer websites have been removed
    • U.S. telecom regulator has taken series of steps to crack down on Chinese telecoms
    • Latest action comes amid rising tension between Washington and Beijing on numerous fronts

    WASHINGTON, Oct 10 (Reuters) – The chair of the Federal Communications Commission said on Friday that major U.S. online retail websites have removed millions of listings for prohibited Chinese electronics as part of a crackdown by the agency.

    FCC Chair Brendan Carr said in an interview that the items removed are either on a U.S. list of barred equipment or were not authorized by the agency, including items like security cameras and phones from companies like Huawei and ZTE (000063.SZ), opens new tab. He said companies are putting new processes in place to prevent future prohibited items as a result of FCC oversight.

    Sign up here.

    “We’re going to keep our efforts up,” Carr said.

    U.S. agencies in recent years have taken a series of actions against Chinese tech companies, including telecom, semiconductors, vehicles and others raising national security concerns. This is the latest push to prevent unapproved Chinese electronics from getting to the U.S. market.

    Earlier this week, the FCC said it plans to vote this month to tighten restrictions on telecommunications equipment made by Chinese companies deemed national security risks, the latest in a series of U.S. actions targeting Beijing.

    The U.S. telecom regulator previously named companies including Huawei Technologies, ZTE (000063.SZ), opens new tab, Hangzhou Hikvision (002415.SZ), opens new tab, China Mobile (600941.SS), opens new tab and China Telecom (601728.SS), opens new tab to the so-called “Covered List,” which bars the FCC from authorizing the import or sale of new equipment from those companies.

    The agency will vote on October 28 to prohibit authorization of devices containing component parts that are on the Covered List and authorize the agency to prohibit the sale of previously authorized Covered List equipment in specific cases.

    In March, the FCC said it was investigating nine Chinese companies on the Covered List including Huawei, ZTE as well as Hytera Communications (002583.SZ), opens new tab, Dahua Technology Company (002236.SZ), opens new tab, Pacifica Networks/ComNet and China Unicom (Americas) (0762.HK), opens new tab.

    The Chinese embassy in Washington did not immediately comment.

    The FCC previously barred some Chinese companies from providing telecommunications services in the United States, citing national security concerns.

    Last month, the FCC began proceedings to withdraw recognition from seven test labs owned or controlled by the Chinese government, citing U.S. national security concerns.

    Reporting by David Shepardson; Editing by Mark Porter and Diane Craft

    Our Standards: The Thomson Reuters Trust Principles., opens new tab

    Continue Reading